{"transactions":[{"id":1516092,"issuer":{"id":6478,"kind":"organization","name":"Humacyte, Inc.","symbol":"HUMA"},"owners":[{"id":91039,"kind":"person","name":"Binder Gordon M","position":1,"cik":"0001291957","reported_name":"Binder Gordon M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-15T23:24:07.000Z","date":"2024-05-15","kind":"purchase","planned":false,"acquired":true,"shares":50000,"price":6.78,"value":339000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price is a weighted average price. The shares were purchased in multiple transactions at per share prices ranging from $6.64 to $6.96. The Reporting Person undertakes to provide upon request to the SEC staff, or any stockholder of the Issuer, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":160000,"source":{"system":"sec-edgar","filing":"0001818382-24-000058","document":"wk-form4_1715815434.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1818382/000181838224000058/wk-form4_1715815434.xml","form_type":"4"}},{"id":1516091,"issuer":{"id":6478,"kind":"organization","name":"Humacyte, Inc.","symbol":"HUMA"},"owners":[{"id":91039,"kind":"person","name":"Binder Gordon M","position":1,"cik":"0001291957","reported_name":"Binder Gordon M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-15T23:24:07.000Z","date":"2024-05-15","kind":"purchase","planned":false,"acquired":true,"shares":50000,"price":6.57,"value":328500.0,"ownership":{"direct":false,"nature":"By the Binder Trust dated 15 July 2003"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price is a weighted average price. The shares were purchased in multiple transactions at per share prices ranging from $6.44 to $6.59. The Reporting Person undertakes to provide upon request to the SEC staff, or any stockholder of the Issuer, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":50000,"source":{"system":"sec-edgar","filing":"0001818382-24-000058","document":"wk-form4_1715815434.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818382/000181838224000058/wk-form4_1715815434.xml","form_type":"4"}},{"id":1852543,"issuer":{"id":6478,"kind":"organization","name":"Humacyte, Inc.","symbol":"HUMA"},"owners":[{"id":91039,"kind":"person","name":"Binder Gordon M","position":1,"cik":"0001291957","reported_name":"Binder Gordon M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2023-06-16T20:10:54.000Z","date":"2023-06-15","kind":"grant","planned":false,"acquired":true,"shares":8500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The first 25% of the option becomes exercisable on June 15, 2024, after which 1/48 of the option will become exercisable on the 15th of each month through June 15, 2027."}],"balance_after":8500,"derivative":{"exercise_price":3.35,"expiration_date":"2033-06-15","underlying":"Common Stock","underlying_shares":8500},"source":{"system":"sec-edgar","filing":"0001818382-23-000088","document":"wf-form4_168694623409421.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818382/000181838223000088/wf-form4_168694623409421.xml","form_type":"4"}},{"id":2165841,"issuer":{"id":6478,"kind":"organization","name":"Humacyte, Inc.","symbol":"HUMA"},"owners":[{"id":91039,"kind":"person","name":"Binder Gordon M","position":1,"cik":"0001291957","reported_name":"Binder Gordon M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-09-06T20:14:39.000Z","date":"2022-09-02","kind":"purchase","acquired":true,"shares":61841,"price":4.4,"value":272100.4,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were purchased in multiple transactions at per share prices ranging from $4.20 to $4.70. The Reporting Person undertakes to provide upon request to the SEC staff, or any stockholder of the Issuer, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":110000,"source":{"system":"sec-edgar","filing":"0001818382-22-000119","document":"wf-form4_166249526500566.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818382/000181838222000119/wf-form4_166249526500566.xml","form_type":"4"}},{"id":2169081,"issuer":{"id":6478,"kind":"organization","name":"Humacyte, Inc.","symbol":"HUMA"},"owners":[{"id":91039,"kind":"person","name":"Binder Gordon M","position":1,"cik":"0001291957","reported_name":"Binder Gordon M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-09-01T21:28:59.000Z","date":"2022-09-01","kind":"purchase","acquired":true,"shares":48159,"price":4,"value":192636.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were purchased in multiple transactions at per share prices ranging from $3.53 to $4.20. The Reporting Person undertakes to provide upon request to the SEC staff, or any stockholder of the Issuer, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":48159,"source":{"system":"sec-edgar","filing":"0001818382-22-000117","document":"wf-form4_166206771163271.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818382/000181838222000117/wf-form4_166206771163271.xml","form_type":"4"}},{"id":2234306,"issuer":{"id":6478,"kind":"organization","name":"Humacyte, Inc.","symbol":"HUMA"},"owners":[{"id":91039,"kind":"person","name":"Binder Gordon M","position":1,"cik":"0001291957","reported_name":"Binder Gordon M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2022-06-13T20:24:00.000Z","date":"2022-06-09","kind":"grant","acquired":true,"shares":8500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The first 25% of the option becomes exercisable on June 9, 2023, after which 1/48 of the option will become exercisable on the 9th of each month through June 9, 2026."}],"balance_after":8500,"derivative":{"exercise_price":4.34,"expiration_date":"2032-06-09","underlying":"Common Stock","underlying_shares":8500},"source":{"system":"sec-edgar","filing":"0001818382-22-000097","document":"wf-form4_165515180978252.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818382/000181838222000097/wf-form4_165515180978252.xml","form_type":"4"}},{"id":2541762,"issuer":{"id":6478,"kind":"organization","name":"Humacyte, Inc.","symbol":"HUMA"},"owners":[{"id":91039,"kind":"person","name":"Binder Gordon M","position":1,"cik":"0001291957","reported_name":"Binder Gordon M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2021-10-15T19:43:59.000Z","date":"2021-10-13","kind":"grant","acquired":true,"shares":13000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The first 25% of the option becomes exercisable on October 13, 2022, after which 1/36 of the option will become exercisable on the 13th of each month through October 13, 2025."}],"balance_after":13000,"derivative":{"exercise_price":10.03,"expiration_date":"2031-10-13","underlying":"Common Stock","underlying_shares":13000},"source":{"system":"sec-edgar","filing":"0001104659-21-126721","document":"tm2130120-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818382/000110465921126721/tm2130120-1_4seq1.xml","form_type":"4"}}]}